Page last updated: 2024-08-25

rebeccamycin and Cancer of Lung

rebeccamycin has been researched along with Cancer of Lung in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anizon, F; Léonce, S; Marminon, C; Moreau, P; Pfeiffer, B; Pierré, A; Prudhomme, M; Renard, P	1
Dowlati, A; Fu, P; Halmos, B; Ivy, P; Ma, PC; Mekhail, T; O'Brien, T; Schwandt, A	1
Chapman, R; Cortas, T; Dowlati, A; Fu, P; Ivy, P; Levitan, N; Ness, A; Patrick, L; Remick, SC; Reynolds, S; Subbiah, S; Xu, N	1

Trials

2 trial(s) available for rebeccamycin and Cancer of Lung

Article	Year
Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:4 Topics: Aged; Antibiotics, Antineoplastic; Carbazoles; Carcinoma, Small Cell; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors	2012
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer. Investigational new drugs, 2005, Volume: 23, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Carbazoles; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Survival Analysis	2005

Article

Year

Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:4

Topics: Aged; Antibiotics, Antineoplastic; Carbazoles; Carcinoma, Small Cell; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors

2012

Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.

Investigational new drugs, 2005, Volume: 23, Issue:6

Topics: Adult; Aged; Antibiotics, Antineoplastic; Carbazoles; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Survival Analysis

2005

Other Studies

1 other study(ies) available for rebeccamycin and Cancer of Lung

Article	Year
Syntheses and antiproliferative activities of new rebeccamycin derivatives with the sugar unit linked to both indole nitrogens. Journal of medicinal chemistry, 2002, Mar-14, Volume: 45, Issue:6 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Indoles; K562 Cells; Leukemia L1210; Lung Neoplasms; Mice; Pyrazoles; Tumor Cells, Cultured	2002

Article

Year

Syntheses and antiproliferative activities of new rebeccamycin derivatives with the sugar unit linked to both indole nitrogens.

Journal of medicinal chemistry, 2002, Mar-14, Volume: 45, Issue:6

Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Indoles; K562 Cells; Leukemia L1210; Lung Neoplasms; Mice; Pyrazoles; Tumor Cells, Cultured

2002